Colgate Palmolive (India) Ltd.
FMCG · NSE
52-week range
₹1,782 – ₹2,689
From 52w high
-18.3%
RSI (14)
65.1
vs SMA 50 / 200
↑ 50 · ↑ 200
Colgate-Palmolive (India) trades at ₹2,197.40, above both its 50-DMA (₹2,049.63) and 200-DMA (₹2,160.46), with RSI at 65.1. The stock is down 14.35% over 12 months and 18.28% off its 52-week high, while carrying a PE of 44.97 — second-lowest among its 6 FMCG peers. Five-year earnings growth is 0.3% and revenue growth is 1.7%, with a debt-to-equity of 3.79 standing out as the highest leverage ratio in its peer group.
- ✓Positive FCF in 4 of 5 available years and a consistency score of 74 indicate sustained cash generation despite muted earnings growth.
- ✓Profit margin of 22.48% is high in absolute terms, suggesting the core oral-care business retains pricing power over costs.
- ✓Debt trend is classified as falling, meaning the elevated D/E of 3.79 has been moving in the right direction rather than compounding.
- ✓PE of 44.97 is the second-lowest in the FMCG peer group (peers range up to 81.6 for NESTLEIND), with a forward PE of 40.95 indicating expectations of some earnings improvement.
- ✗D/E of 3.79 is a significant outlier versus FMCG peers; the sector is typically associated with low-leverage business models, and COLPAL departs sharply from that norm.
- ✗5-year earnings growth of 0.3% and revenue growth of 1.7% reflect near-stagnant compounding; profit margins have been preserved but the absolute profit base has barely expanded.
- ✗Quality score of 44 ranks COLPAL 5th of 6 FMCG peers, with only ITC (also 44) at the same level; sector leaders HINDUNILVR (58), NESTLEIND (61), and BRITANNIA (50) score materially higher.
- ✗Mean analyst rating of 3.11 across 27 analysts (1–5 scale, lower = more constructive) places consensus closer to the mid-point of the scale, reflecting a more divided analyst view than most large-cap FMCG peers.
- ·All 3 retrieved news items over the analysis window are rated neutral; no material positive or negative catalysts appear in recent coverage.
- ·COLPAL backed the IEPF Saksham Niveshak initiative to resolve unclaimed dividends — a governance-adjacent action with no direct financial impact reported.
- ·The stock has recovered 3.84% over the past 3 months and is now above both its 50-DMA and 200-DMA, after a longer period of underperformance that left the 12-month return at -14.35%.
- ?Does the elevated D/E of 3.79 reflect a structural capital-allocation decision (e.g., dividend recapitalization, brand investment) or operational cash needs — and is the falling debt trend fast enough to approach sector norms?
- ?With 5-year earnings growth at 0.3%, what would need to change in volume, pricing, or product mix for COLPAL to re-accelerate earnings compounding comparable to its historical profile?
- ?The stock currently sits between near-term resistance at ₹2,209.90 and support at ₹2,064 — how has the stock historically behaved at these technical levels during periods of broader FMCG sector volatility?
- ?Does the mid-range analyst consensus (3.11 on a 1–5 scale across 27 analysts) reflect genuine disagreement on COLPAL's growth outlook, or are there specific business lines or market segments where views diverge sharply?
PE
45.0
Forward PE
40.9
ROE
—
Profit margin
+22.5%
D/E
3.79
Dividend yield
+2.3%
Quality score
44/100
ROE 5y above 15%
4/5 yrs
FCF 5y positive
4/5 yrs
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.Analysis generated 11 May 2026.